Clincosm LogoSign in Get a demo

recurrent pancreatic cancer

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Memphis, Nashville (drug,

Terminated
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Memphis, Tennessee
  • +1 more
Jun 23, 2014

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Liver Metastases Trial in Duarte

Withdrawn
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +7 more
  • dynamic contrast-enhanced magnetic resonance imaging
  • +2 more
  • Duarte, California
    City of Hope Medical Center
May 28, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in New York (alvocidib, docetaxel)

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
May 12, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (cetuximab, gemcitabine

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +4 more
  • cetuximab
  • +3 more
  • Chicago, Illinois
    University of Chicago
Apr 28, 2014

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,

Terminated
  • Adenocarcinoma of the Pancreas
  • +25 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Apr 1, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Cleveland (sunitinib malate,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • sunitinib malate
  • gemcitabine hydrochloride
  • Cleveland, Ohio
    Case Western Reserve University
Feb 21, 2014

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Hamilton, Toronto

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • +3 more
  • Hamilton, Ontario, Canada
  • +1 more
Feb 21, 2014

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2013

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer Trial in

Completed
  • Advanced Adult Primary Liver Cancer
  • +87 more
  • Charlottesville, Virginia
    University of Virginia
Sep 27, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (sorafenib tosylate,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • gemcitabine hydrochloride
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jul 1, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Chicago (drug, biological,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • gemcitabine hydrochloride
  • +5 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 4, 2013

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • sunitinib malate
  • Chicago, Illinois
  • +1 more
Jun 3, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia

Completed
  • Adenocarcinoma of the Colon
  • +41 more
  • recombinant fowlpox-CEA(6D)/TRICOM vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 24, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (drug, biological,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • gemcitabine hydrochloride
  • +2 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 23, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Houston

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 22, 2013

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in Houston (temsirolimus,

Completed
  • Adenocarcinoma of the Pancreas
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 16, 2013

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Fallopian Tube Cancer Trial in Philadelphia (EF5, motexafin

Terminated
  • Advanced Adult Primary Liver Cancer
  • +70 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jan 15, 2013

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,

Completed
  • Adult Anaplastic Astrocytoma
  • +85 more
  • erlotinib hydrochloride
  • laboratory biomarker analysis
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jan 15, 2013